About the Institute for Global Health & Infectious Diseases
Established in 2007, the Institute for Global Health & Infectious Diseases (IGHID) brings transformative solutions to the most important global health issues of our time, through research, training and service. The IGHID has saved millions of lives and shaped policy worldwide through cutting-edge research, especially in the areas of HIV, Malaria and now COVID, where UNC is the most cited university in the nation for coronavirus research. Working in over 50 countries around the globe, the IGHID provides a unique pan-university framework for collaboration and facilitating global health science and practice. It is this framework that continues to catalyze a global health community committed to improving health worldwide while building the capacity of thousands of scientists and health professionals globally.
The fight against the acquired immunodeficiency syndrome (AIDS) epidemic has made huge strides in recent years, but there is still much more work to be done. What role technology will play in that effort has yet to be determined.
There are several areas of the country where the acquired immunodeficiency syndrome (AIDS) epidemic remains to be a problem. Both minorities and those in the southern states are seeing a continued problem with the disease, while the northern states are seeing improvements in numbers.
As the battle against the acquired immunodeficiency syndrome (AIDS_ epidemic continues, a project funded by the National Institutes of Health (NIH) is looking at different ways to use technology to help in the prevention and care of the human immunodeficiency virus (HIV) and AIDS.
If research continues focusing on macrophages and their role in the human immunodeficiency virus (HIV), it could mean new opportunities to treat patients and eventually help find a cure.
In previous studies it had been shown that macrophages were not targeted by HIV when looking at how the virus develops. New research of mouse models has shown evidence that that may not be the case.
The human immunodeficiency virus (HIV) is no longer the death sentence it was when the virus was first discovered in 1983. Although patients are living better, longer lives, finding a cure to the disease remains a top priority.
Through 30 years of research HIV has gone from being a death sentence for patients to something that can be more of a chronic condition. Antiretroviral therapy has been a key part of that fight and now there is more good news about this treatment option.